Warfarinized Patients: Perioperative Mild to Moderate Hemorrhage Undergoing Oral Surgery and Management - A Systematic Review
DOI:
https://doi.org/10.3329/bjms.v24i10.79802Keywords:
Medicine to Prevent Blood Clots, Vitamin K antagonist, Anticoagulation, Tooth Extraction, Oral Surgery, Postoperative Bleeding, Deep Vein Thrombosis, Pulmonary Embolism, Hemostatic Measures, A Clinical ConundrumAbstract
Background The management of patients on warfarin therapy during oral surgical procedures, specifically tooth extractions, has been subject to significant clinical debate. The risk of postoperative bleeding must be balanced against the potential for thromboembolic events upon discontinuation of anticoagulation. This study synthesized findings from various research efforts to elucidate the safety and efficacy of continuing warfarin therapy during dental extractions. Methods A comprehensive literature review examined studies that included patients undergoing tooth extractions while on warfarin therapy. Following the PRISMA guidelines, data were extracted on patient outcomes, particularly the incidence and severity of postoperative bleeding and the use and effectiveness of local hemostatic measures. Results The 6 included papers consistently demonstrated that most patients on warfarin therapy experienced minor bleeding complications postextraction, with severe bleeding events being rare. Local hemostatic measures, including mechanical pressure and pharmacological agents, effectively managed to bleed. The studies varied in terms of hemostatic agents used and pain assessment. Still, the overarching inference pointed towards the safety of continuing warfarin therapy during dental extractions with appropriate local hemostasis. Conclusion Continuing warfarin therapy during dental extractions appears safe for patients with an INR (International Normalized Ratio) maintained within therapeutic ranges. The evidence does not support the necessity for preoperative alteration of warfarin therapy, provided that effective local hemostatic measures are in place. Clinical decisions should be individualized based on patient risk assessments for both bleeding and thromboembolism.
BJMS, Volume: 24. Supplementary Issue 2025, Page : 9-23
Downloads
197
198
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Fazil Arshad Nasyam, Ankur Jethlia, Honey Lunkad, Pankaj Kukreja, Rajendran Ganesh, Shaista Haleem, Mainul Haque, Santosh Kumar

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:
- Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.
Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.